M&A Deal Summary

Biovertis AG Acquires Morphochem AG

On December 1, 2005, Biovertis AG acquired life science company Morphochem AG

Acquisition Highlights
  • This is Biovertis AG’s 1st transaction in the Life Science sector.
  • This is Biovertis AG’s 1st transaction in Germany.

M&A Deal Summary
Date 2005-12-01
Target Morphochem AG
Sector Life Science
Buyer(s) Biovertis AG
Deal Type Add-on Acquisition

Target

Morphochem AG

Munich, Germany
Morphochem AG is a rapidly growing biopharmaceutical company with core expertise in creating highly diverse compound libraries using novel multi-component chemistries.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Biovertis AG

Vienna, Austria
Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Biovertis AG develops drugs for the treatment of infections caused by pathogenic bacteria.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2005) 1 of 1
Mergr

Product

Company

Legal